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Background: A diversifying pool of mammalian- adapted influenza A viruses (IAV) with 
largely unknown zoonotic potential is maintained in domestic swine populations 
worldwide. The most recent human influenza pandemic in 2009 was caused by a virus 
with genes originating from IAV isolated from swine. Swine influenza viruses (SIV) are 
widespread in European domestic pig populations and evolve dynamically. Knowledge 
regarding occurrence, spread and evolution of potentially zoonotic SIV in Europe is 
poorly understood.
Objectives: Efficient SIV surveillance programmes depend on sensitive and specific 
diagnostic methods which allow for cost- effective large- scale analysis.
Methods: New SIV haemagglutinin (HA) and neuraminidase (NA) subtype- and lineage- 
specific multiplex real- time RT- PCRs (RT- qPCR) have been developed and validated 
with reference virus isolates and clinical samples.
Results: A diagnostic algorithm is proposed for the combined detection in clinical sam-
ples and subtyping of SIV strains currently circulating in Europe that is based on a 
generic, M- gene- specific influenza A virus RT- qPCR. In a second step, positive sam-
ples are examined by tetraplex HA- and triplex NA- specific RT- qPCRs to differentiate 
the porcine subtypes H1, H3, N1 and N2. Within the HA subtype H1, lineages “av” 
(European avian- derived), “hu” (European human- derived) and “pdm” (human pan-
demic A/H1N1, 2009) are distinguished by RT- qPCRs, and within the NA subtype N1, 
lineage “pdm” is differentiated. An RT- PCR amplicon Sanger sequencing method of 
small fragments of the HA and NA genes is also proposed to safeguard against failure 
of multiplex RT- qPCR subtyping.
Conclusions: These new multiplex RT- qPCR assays provide adequate tools for sus-
tained SIV monitoring programmes in Europe.
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1  | INTRODUCTION
Influenza A virus (IAV) infections have a significant clinical impact on 
domestic swine populations. This is mainly related to acute respiratory 
disease which is frequently exacerbated by synergistic viral and bacte-
rial co- infections. Economic losses for the pork producing industry due 
to swine influenza virus (SIV) infections can be substantial.1–3
Swine are susceptible to infection from various IAV subtypes of 
both mammalian and avian origin. This is due to the expression of 
cellular glycan moieties (alpha 2- 6 or 2- 3- linked terminal sialic acids, 
respectively) in the porcine upper respiratory tract that act as recep-
tors for viral attachment by the haemagglutinin protein (HA) of both 
avian and mammalian IAV.4–6 Thus, simultaneous infection of porcine 
cells with mammalian/human and avian IAV is possible. Such double 
infections open possibilities for an exchange of genome segments 
between these viruses (reassortment) and progeny viruses with 
mixed parental genotypes (reassortants) potentially leading to the 
emergence of new phenotypic properties. For this reason, pigs have 
been dubbed mixing vessels of IAV.7–10 Historically, the evolution of 
human and porcine influenza viruses has been intimately interlinked 
over at least one century in that new influenza virus reassortants have 
emerged in swine populations following trans- species transmission 
of IAV from infected humans in the course of human IAV pandemics 
(so- called reverse zoonotic transmission).11 However, direct infec-
tion of swine with IAV of purely avian origin has also occurred.12 In 
swine, some of these viruses swiftly established porcine- adapted, 
independently circulating lineages which reassorted amongst each 
other. As a result of these processes, a variety of sublineages and 
genotypes of SIV is now prevalent in swine populations worldwide, 
but with some geographic restrictions,.13,14 Some of these viruses 
may have zoonotic potential and can be retransmitted into the human 
population.15–17
Until 2009, the IAV subtypes H1N1, H1N2 and H3N2 circulat-
ed in domestic pigs at variable rates in Europe. The current enzootic 
Eurasian SIV H1N1 lineage is of purely avian origin and was introduced 
to pigs from unknown bird populations in the late 1970s. These virus-
es are referred to as “avian- like” (av) H1N1 and are genetically and 
antigenically distinct from the “classical” (human 1918- derived) H1N1 
SIVs which continue to circulate in North America and some parts of 
Asia, but not in Europe.13,18 Reassortment of viruses of the Eurasian 
H1N1av lineage with human seasonal H3N2 viruses gave rise to the 
porcine H3N2 lineage in which HA and NA are of human origin, while 
the other six genome segments are of avian descent.14 In 1994, an 
H1N2 reassortant (H1huN2) comprising the HA gene from a human 
seasonal H1N1 virus, the NA gene from H3N2 human- like SIV and 
internal genes from H1N1 avian- like SIV was first identified in the 
United Kingdom and subsequently detected in many further European 
countries.19 In 2003, a new H1N2 SIV reassortant virus was found in 
Danish pigs.20 This H1N2 virus comprised an avian- like HA gene and 
an NA from contemporary circulating H3N2 SIV and have since been 
found in several other European countries.18 Apart from these domi-
nant enzootic strains, several reassortants between these viruses have 
been described in Europe, but no sustained spread of such viruses has 
been reported as yet.21
Following the emergence of the human pandemic H1N1 2009 
influenza A virus (H1N1pdm), a fourth IAV lineage entered swine 
populations globally. Pigs were found to be highly susceptible to this 
virus,22 and spread within swine populations, independent of human 
infections, is ongoing. An increasing amount of reassortants between 
porcine- adapted enzootic IAV and the H1N1pdm virus have been 
described. Some of these reassortant lineages, such as the H1pdmN2 
lineage reported from Germany, have been in regional circulation for 
several years now 23 and several retained the so- called TRIG cassette 
of internal gene segments of the H1N1pdm virus and therefore may 
carry substantial zoonotic and even pandemic potential.16,21
Despite coordinated European research efforts in surveillance of 
porcine IAV, such as the ESNIP consortium,18 data on the occurrence, 
spread and evolution of potentially zoonotic SIV in Europe remain 
fragmentary. This not only impedes the early detection of emerging 
SIV reassortants with increased zoonotic potential but may also inter-
fere with the development and updating of efficacious influenza virus 
vaccines for use in pigs.2,3 A prerequisite for efficient SIV surveillance 
programmes is sensitive and specific diagnostic methods which allow 
for high- throughput analysis. Classically, SIV diagnosis is based on 
virus isolation in MDCK cells and serological subtype characterization 
by haemagglutination inhibition (HI) assays. However, this has recently 
been superseded by IAV- generic real- time RT- PCRs (RT- qPCR).24–27 
Molecular subtype characterization has, however, depended on time- 
consuming sequencing of fragments of the HA and NA genes or on 
subtype- specific, conventional RT- PCRs.28–30
Here we present two multiplex RT- qPCRs to facilitate the detec-
tion and differentiation of four and three lineages of HA and of NA 
gene segments, respectively, of SIV subtypes which currently cocir-
culate in European swine populations. In combination with a generic 
IAV- specific duplex RT- qPCR (enhanced by an internal control), we 
propose a diagnostic algorithm for a rapid, sensitive and lineage- 
specific large- scale monitoring of SIV infections in clinical samples 
from swine in Europe.
2  | MATERIAL AND METHODS
2.1 | Field samples, reference viruses
Lung tissue samples or nasal swabs derived from pigs with respiratory 
disease were obtained from swine holdings in several European coun-
tries in the frame of a passive monitoring programme. Samples were 
processed and analysed for SIV RNA by an M- gene- specific RT- qPCR 
as detailed previously.31 Viral RNA of SIV- positive samples was sub-
typed by molecular means using conventional pan- HA and pan- NA 
RT- PCRs and amplicon Sanger sequencing.32,33 In addition, virus isola-
tion in MDCK cell cultures was attempted and isolates were subtyped 
by either full- length nucleotide sequence analysis of the HA and NA 
genome segments as described elsewhere 34 or amplicon sequencing of 
short HA and NA fragments. influenza A viruses of other host species 
     |  3Henritzi et al.
were retrieved from the reference collections at FLI (Friedrich- Loeffler- 
Institut, Greifswald- Insel Riems, Germany) or RKI (Robert- Koch- Institut, 
Berlin, Germany) and used for RT- qPCR validation purposes. Similarly, 
other porcine respiratory pathogens of viral and bacterial nature were 
used for assessing analytical specificity (Table S1).
2.2 | Design of primers and probes
Primers and probes for subtype and/or lineage- specific detection of 
HA and NA for use in multiplexed RT- qPCRs were either selected 
from previously published assays (H1pdm: 35 N1 and N2 (Hoffmann 
et al.36 (2016) or manually selected (H1av, H1hu, H3, N1pdm) from 
alignments comprising full- length HA and NA sequences of European 
SIV detected since year 2000; sequences were retrieved from the 
Influenza Research (IRD) and Global Initiative on Sharing All Influenza 
Data (GISAID) databases. Melting temperatures and basic proper-
ties of oligonucleotides were approximated using the online tool 
“Oligocalc”.37 Preliminary versions of the primer and probe sets were 
evaluated with European SIV isolates previously identified 18 in labo-
ratories in France, Italy, United Kingdom, Denmark and Germany 
during the ESNIP3 concerted action. Based on these results, fur-
ther rounds of optimizing oligonucleotide sequences were initiated. 
Table 1 lists the final sets of primers and probes for RT- qPCRs (A) and 
conventional RT- PCRs (B).
2.3 | One- step RT- qPCR
The AgPath- IDTM One- Step RT- PCR kit (Ambion, Foster City, CA, 
USA) was used throughout. Thermocycling conditions on a Bio- Rad 
CFX96 real- time PCR detection system were optimized by adapting 
annealing time and temperature. These cycling conditions were found 
to be optimal for the generic M- specific RT- qPCR38:
• 10 minutes 45°C, 10 minutes 95°C, 42 cycles each of 15 seconds 
95°C – 20 seconds 55°C – 30 seconds 72°C.
The cycling conditions for the multiplex HA- and NA- specific RT- 
qPCRs were found to be optimal at:
• 10 minutes 45°C, 10 minutes 95°C, 42 cycles each of 15 seconds 
95°C – 30 seconds 58°C – 30 seconds 72°C.
The fluorescence data were collected during the annealing step of 
55°C and 58°C, respectively, in all runs.
2.4 | Conventional one- step RT- PCR
Superscript III One- Step RT- PCR kit with Platinum Taq polymerase 
(Invitrogen TM GmbH, Karlsruhe, Germany) was used for conventional 
RT- PCR. Thermocycling conditions on an Analytik Jena Flex Cycler or 
a SensoQuest Labcycler were optimized by adapting annealing time 
and temperature. These cycling conditions were found to be optimal 
for the generic pan- HA and pan- NA 32,33 RT- PCRs:
• 30 minutes 50°C, 2 minutes 94°C, 45 cycles each of 30 seconds 
94°C – 45 seconds 50°C – 45 seconds 68°C, final elongation 5 min-
utes 68°C.
The cycling conditions for an optimized version of the generic pan- 
HA- SIV RT- PCR were found to be optimal at:
• 30 minutes 48°C, 2 minutes 94°C, 45 cycles each of 30 seconds 
94°C – 30 seconds 55°C – 40 seconds 68°C, final elongation 2 min-
utes 68°C.
2.5 | Sequencing
The subtype and lineage of SIV isolates and PCR- positive field sam-
ples were determined by Sanger sequencing of RT- PCR- amplified 
fragments of the HA and NA gene segments using the pan- HA and 
pan- NA conventional RT- PCRs described by Gall et al.32,33 (2008, 
2009) and further modified in this study. These PCRs generate an 
HA fragment of approximately 180 bp spanning the HA cleavage site 
and a 630- bp fragment of the 5′ region of the NA gene segment. For 
selected SIV isolates, full- length HA and NA sequences were obtained 
using RT- PCRs described by Starick et al.34 (2011). Specific amplicons 
were purified from 1.5% agarose gels using a QIAquick gel extraction 
kit (Qiagen, Hilden, Germany) and Sanger- sequenced using the RT- 
PCR primers. The sequences were analysed on an ABI 310 sequencer, 
curated using the Chromas Lite® software (http://www.technelysium.
com.au/Chromas250Setup.exe) and assembled using the CAP3 pro-
gramme (http://doua.prabi.fr/software/cap3).
2.6 | Molecular sequence analyses
The IRD or GISAID databases were screened with BLASTN2 to iden-
tify closely related sequences of the pan- HA and pan- NA sequences.
3  | RESULTS
3.1 | Assembly and analytical performance of 
subtype- specific uniplex RT- qPCRs for the detection 
and differentiation of HA and NA lineages of European 
SIV
Significant sequence variation exists within and between the HA and 
NA subtypes and lineages of SIV from Europe. Sequence stretches 
conserved within one lineage, yet distinctively different from other 
lineages were found to be rare even if only the 3′ termini of poten-
tial primers and/or the central region of probes were considered. 
Extensive in silico analysis showed that degeneration of primers at up 
to four positions or the use of more than two primers per PCR was 
inevitable to span the whole width of (published) sequence variation 
within a single lineage (Table 1). Primers selected by this strategy for 
the human- derived H1huN2 lineage gave rise to false (cross- subtype- ) 
priming and resulted in non- specific amplification (data not shown). 
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TABLE  1 Attributes of primers and probes employed in tetra- and triplex RT- qPCRs (A) or in multiplex RT- PCR (B) for the detection of HA 
and NA lineages, respectively, of swine influenza viruses currently circulating in Europe
Primer/Probe Concentration Sequence, labelling Location Product size Reference sequence
(A)
Hemagglutinin
H1av
H1av_Sw_Fn 20 pmol/rxn gaaggrggatggacaggratra 1063–1084 134–139 bp A/swine/Germany/
SIV04/2008 (H1N1)
H1av_Sw_R1 10 pmol/rxn actgagttcactttgttrytk 1176–1196 FN429078
H1av_Sw_R2 10 pmol/rxn caattahtgarttcactttgttgy 1178–1201
H1av_Sw_HEX_1 2,5 pmol/rxn HEX- tctggttaygcagcwgatmagaaaa- BHQ1 1126–1150
H1hu
H1hu_Sw_F_2 10 pmol/rxn ggatggtacggttaycayca 1090–1109 115–208 bp A/swine/Kitzen/
IDT6142/2007 (H1N2)
H1[N2]_Swine_Fw 10 pmol/rxn gagggggrtggaccggaatgatagatgga[i]5tggttatc
atca
1064–1109 GQ161145
H1hu_Sw_R_2 10 pmol/rxn tttcgatcacagaattcacct 1184–1204
H1[N2]_Swine_Rv 10 pmol/rxn acctacagctgtgaattgagtgttcatyttntcg[i]5agagt
tcacct
1184–1233
H1hu_Sw_ROX 2,5 pmol/rxn ROX- cagggwtctgghtatgctgcdgacc- BHQ2 1120–1144
H1pdm
H1pdm_Fw 10 pmol/rxn ctagtggtaccgagatatgca 793–813 88 bp A/Germany- MV/
R26/2011 (pdmH1N1)
H1pdm_Rv 10 pmol/rxn tattgcaatcgtggactggtgt 859–880 EPI356430
H1pdm_FAM 1 pmol/rxn FAM- cgcaatggaaagaaatgctggatctgg- BHQ1 816–842
H3
H3_Sw_F2 10 pmol/rxn ggggaccctcaytgtga 262–278 100 bp A/swine/
Bakum/8602/99 (H3N2)
H3_Sw_R2 10 pmol/rxn actcyggcacrtcatahgg 343–361 EF409250
H3_Sw_Q670 2,5 pmol/rxn Cy5- ttgaacgcagcarrgctttcagca- BHQ3 311–334
Neuraminidase
N1all
N1.3_F 12,5 pmol/rxn agrccttgyttctgggttga 1255–1274 126 bp A/swine/Germany/
SIV04/2008 (H1N1)
N1.3_R 12,5 pmol/rxn accgtctggccaagacca 1363–1380 FN429079
AIV_N1.3_FAM 1,5 pmol/rxn FAM- atytggacyagtgggagcagcat- BHQ1 1306–1328
N1pdm
N1pdm_FW_2 10 pmol/rxn caacacttgggtaaatcaga 174–193 74 bp A/Germany- MV/
R26/2011 (pdmH1N1)
N1pdm_RV_2 10 pmol/rxn cggaaaccactgactgtc 230–247 EPI356429
N1pdm_SO_2 2,5 pmol/rxn ROX- catcagcaacaccaactttgctgct- BHQ2 204–228
N2all
N2_1367F 15 pmol/rxn agtctggtggacytcaaayag 1305–1325 116 bp A/swine/
Bakum/8602/99 (H3N2)
N2_1468R 15 pmol/rxn ttgcgaaagcttatatagvcatga 1397–1420 EF409258
AIV_N2_1444_
HEX
2,5 pmol/rxn HEX- ccatcaggccatgagcctgwwccata- BHQ1 1357–1382
(B)
panHA a
HA- 1057.1- F 5 pmol/rxn ggrgaatgccccaaataygt 952–971 180 bp A/swine/Germany/
SIV04/2008 (H1N1)
HA- 1057.2- F 5 pmol/rxn ggraratgccccagrtatgt 952–971 FN429078
HA- 1057.3- F 5 pmol/rxn ggrgaatgccccaartayat 952–971
HA- 1232.1(555)- R 5 pmol/rxn ctgagtccgaacattgagttgctatgvtgrtawccatacca 1093–1115
HA- 1232.2(555)- R 5 pmol/rxn ctgagtccgaacattgagttytgatgyctgaadccrtacca 1093–1115
panHA-SIV
H1av
PAN_H1av_DH_F 5 pmol/rxn ggrgaatgccccaaataygt 952–971 180 bp A/swine/Germany/
SIV04/2008 (H1N1)
PAN_H1av_
DH_R_M13
5 pmol/rxn cgttgtcgatactggtacttgatgrtgatayccataccayc 1091–1113 FN429078
H1hu
(Continues)
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In an attempt to design more specific primers, dual priming oligonu-
cleotides (DPO) were developed. Dual priming oligonucleotides prim-
ers are composed of a longer 5′ sequence stretch which serves as an 
anchor to firmly position the primer at the target site, and degenerate 
nucleotides can be included into this anchor region. The shorter 3′ 
region of the DPO primer of usually less than 12 nucleotides enforces 
highly specific hybridization within a fully matching target sequence. 
The two regions are separated by a stretch of five inosine residues.30,38
RNA obtained from a panel of 20 IAV of subtype H1, H3, N1 and 
N2 of human, avian or porcine origin was used to evaluate different 
sets of primers and probes for their analytical specificity for different 
lineages of European SIV. Results shown in Table 2A prove that the 
sets finally chosen discriminated between the HA H1 lineages: (i) pan-
demic H1 (H1pdm), (ii) endemic avian- origin porcine H1 (H1av) and (iii) 
H1 of the human- derived H1N2 subtype (H1hu) and subtype porcine 
H3 (H3). The H1hu RT- qPCR also detected the HA of pre- 2009 sea-
sonal human H1N1 lineage represented by a historic (A/FM/1/1947) 
and a more recent human isolate (A/Germany- NDS/14/2007). This 
(cross- ) reactivity is expected as the porcine H1hu lineage is derived as 
a reassortant from human seasonal H1N1 from the 1990s. No cross- 
reactivity was observed with recent H1 and H3 IAV of avian origin.
In contrast to HA- specific PCRs, no host- specific differentiation 
of N1 and N2 subtypes was attempted. Instead, broadly reacting RT- 
qPCRs for subtypes N1 (N1all) and N2 were established (Hoffmann 
et al.; FLI, Greifswald- Insel Riems, Germany, submitted for publica-
tion) and tested favourably with the reference RNA panel (Table 2B). 
In addition, another RT- qPCR specifically detecting the N1 of the 
human pandemic/2009 H1N1 lineage (N1pdm) was developed. Thus, 
N1pdm- positive viruses gave positive results with both the N1all and 
the N1pdm RT- qPCRs (Table 2B).
None of the primer and probe sets gave false- positive results 
when tested with IAV subtypes H1 and H3 of avian origin (Table 2).
Non- specific reactivity of these PCRs with other porcine viral or 
bacterial respiratory pathogens as listed in Table S1 was excluded.
3.2 | Assembly and analytical performance of 
tetraplex (4plex) and triplex (3plex) RT- qPCRs for the 
detection of haemagglutinin and neuraminidase 
sequences of European SIV
The HA- and NA- specific probes were labelled with different col-
ours: FAM—H1pdm, HEX—H1av, ROX—H1hu, Cy5—H3; FAM—N1, 
ROX—N1pdm, HEX—N2. Primers and probes for each of the four 
HA and for the three NA targets were mixed generating a tetra- and 
a triplex amplification assay, respectively. Series of 10- fold diluted 
RNA of eight representative virus isolates (two for each porcine HA 
subtype/lineage) were used to check for possible impact on the RT- 
qPCR performance that may result from mixing the sets of primer and 
probes. No impairment of performance was noticed. Thus, detection 
continued to be highly lineage- and/or subtype- specific and no cross- 
reaction was evident even in samples with very high virus loads (data 
not shown). Comparison of Cq values of serial 10- fold RNA dilutions 
with results of the generic M- specific RT- qPCR was used to assess 
the relative analytical sensitivity of the multiplex RT- qPCRs. In gen-
eral, relative detection limits of the multiplex RT- qPCRs were slightly 
lower (up to 3 Cq values) than those of the corresponding M RT- qPCR 
(Table 3).
3.3 | Detection of SIV double infections by HA- 
specific tetraplex and NA- specific triplex RT- qPCRs
Infection of the same cell by more than one IAV geno- or subtype 
is the prerequisite of reassortment. The possibility to detect influ-
enza virus co- infections in the same clinical samples is of interest in 
Primer/Probe Concentration Sequence, labelling Location Product size Reference sequence
PAN_H1hu_DH_F 5 pmol/rxn ggrgaatgccccaartaygt 952–971 180 bp A/swine/Kitzen/
IDT6142/2007 (H1N2)
PAN_H1hu_
DH_R_M13
5 pmol/rxn cgttgtcgatactggtaccygrtgatgataaccataccayc 1091–1113 GQ161145
H1pdm
PAN_H1pdm_
DH_F
5 pmol/rxn gtgcyataaacaccagcctc 902–921 230 bp A/Germany- MV/
R26/2011 (pdmH1N1)
PAN_H1pdm_
DH_R_M13
5 pmol/rxn cgttgtcgatactggtacttgatggtgataaccgtaccatc 1091–1113 EPI356430
H3
PAN_H3_DH_F 5 pmol/rxn aacargatcacatatggrgcatg 940–962 195 bp A/swine/
Bakum/8602/99 (H3N2)
PAN_H3_DH_R_
M13
5 pmol/rxn cgttgtcgatactggtacttgrtgyctgaaaccgtaccarc 1094–1116  EF409250
panNA a
NA- 886.1- F 10 pmol/rxn atcgargartgytcntgyta 826–845 631 bp A/swine/Germany/
SIV04/2008 (H1N1)
NA- 886.2- F 10 pmol/rxn gtcgargartgytchtgbta 826–845 FN429079
AIVR- 1458- R 10 pmol/rxn gcagtatatcgcttgacaagtagaaacaagg 1426–1438  
aGall et al.33, 2009.
rxn—volume reaction of 25 μL.
TABLE  1  (continued)
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TABLE  2 Analytical specificity of primers and probes for detection and differentiation of HA (A) and NA (B) lineages of swine influenza 
viruses from Europe. Results are based on uniplex RT- qPCRs
(A) RT- qPCRs targeting the haemagglutinin gene (isolates sorted by HA subtype/lineage)
Isolate identification
Lineage RT- qPCR (Ct- values)
HA NA M1.2 H1pdm H1av H1hu H3
A/Germany/Regensburg/2009 H1pdm N1pdm 23.6 22.5 neg. neg. neg.
A/Germany/NJH- R26/2011 H1pdm N1pdm 20.8 21.2 neg. neg. neg.
A/Swine/Germany/R75/2011 H1pdm N2 18.3 17.9 neg. neg. neg.
A/Swine/Germany/R708/2010 H1pdm N1av 22.2 19.6 neg. neg. neg.
A/Swine/Belzig/2/2001 H1av N1av 18.7 neg. 17.6 neg. neg.
A/Swine/Germany/R819/2010 H1av N1av 21.9 neg. 25.0 neg. neg.
A/Swine/Germany/R248/2010 H1av N1av 23.9 neg. 22.5 neg. neg.
A/Swine/Germany/R1738/2010 H1av N1av 21.0 neg. 17.6 neg. neg.
A/Swine/Germany/R369/2009 H1av N2 23.6 neg. 24.3 neg. neg.
A/Swine/Bakum/1893/2000 H1hu N2 21.9 neg. neg. 22.3 neg.
A/Swine/Germany/R757/2010 H1hu N2 18.6 neg. neg. 21.1 neg.
A/Swine/Germany- NI/R3394/2009 H1hu N1av 21.2 neg. neg. 21.3 neg.
A/Fort Monmoth/1/1947 H1 N1 24.2 neg. neg. 23.5 neg
A/Germany- NDS/14/2007 H1 N1 29.0 neg. neg. 32.9 neg.
A/White- fronted goose/Germany/R482/2009 H1 N1 21.6 neg. neg. neg. neg.
A/Wild duck/Germany/R30/2006 H1 N1 24.9 neg. neg. neg. neg.
A/Swine/Bakum/909/1993 H3 N2 23.2 neg. neg. neg. 22.2
A/Swine/Germany/R96/2011 H3 N2 18.5 neg. neg. neg. 19.2
A/Swine/Germany/R76/2011 H3 N2 21.8 neg. neg. neg. 22.1
A/Waterfowl/Germany/2311/2009 H3 N8 24.7 neg. neg. neg. neg.
A/Germany- BW/23/2007 B B neg. neg. neg. neg. neg.
Tetraplex mixture FAM HEX ROX CY5
(B) RT- qPCRs targeting the neuraminidase gene (isolates sorted by NA subtype/lineage)
Isolate identification
Lineage RT- qPCR (Ct- values)
HA NA M1.2 N1all N1pdm N2
A/Swine/Belzig/2/2001 H1av N1av 14.5 16.3 neg. neg.
A/Swine/Germany- NI/R3394/2009 H1hu N1av 15.3 14.6 neg. neg.
A/Swine/DE/R708/2010 H1pdm N1av 19.0 17.2 neg. neg.
A/Swine/DE/R819/2010 H1av N1av 16.3 16.5 neg. neg.
A/Swine/DE/R248/2010 H1av N1av 19.5 19.7 neg. neg.
A/Swine/DE/R1738/2010 H1av N1av 17.2 17.6 neg. neg.
A/White- fronted goose/Germany/R482/2009 H1 N1 18.0 19.9 neg. neg.
A/Wild duck/Germany/R30/2006 H1 N1 16.2 17.6 neg. neg.
A/Fort Monmoth/1/1947 H1 N1 15.1 15.3 neg. neg.
A/Germany- NDS/14/2007 H1 N1 20.6 19.0 neg. neg.
A/Germany/Regensburg/2009 H1pdm N1pdm 18.7 20.0 20.0 neg.
A/Germany/NJH- R26/2011 H1pdm N1pdm 17.9 18.2 19.1 neg.
A/Swine/Bakum/1893/2000 H1hu N2 16.5 neg. neg. 23.3
A/Swine/Germany/R757/2010 H1hu N2 15.0 neg. neg. 17.0
A/Swine/Germany/R75/2011 H1pdm N2 13.7 neg. neg. 19.1
A/Swine/Germany/R369/2009 H1av N2 18.8 neg. neg. 18.3
A/Swine/Bakum/909/1993 H3 N2 18.8 neg. neg. 19.5
(Continues)
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surveillance programmes. In order to mimic double infections, RNA 
of viruses of four different porcine HA and three NA subtypes/line-
ages, respectively, was mixed to represent all possible combinations 
(Table 4). The RNA of two viruses was mixed in approximately equal 
amounts, in 95:5 and in 5:95 to mimic an up to 20- fold difference in 
RNA content (Table 4). Cq values of the M- specific RT- qPCR were 
used to normalize the concentration of viral RNA, assuming that this 
PCR- amplified viral RNA of the different lineages with similar effi-
cacy. In all cases, both HA and NA (if disparate) targets present in 
the sample were detected and discerned in all mixtures. Again, no 
cross- reactivity to lineages not represented in the sample mix was 
evident.
3.4 | Diagnostic performance of the HA- specific 
tetraplex- and NA- specific triplex RT- qPCRs
A total of 27 SIV isolates obtained in MDCK cell cultures and 27 por-
cine nasal swabs which had tested positive for IAV RNA by M- specific 
RT- qPCR were derived from European swine populations with overt 
respiratory symptoms. In addition, 27 porcine nasal swab samples that 
(B) RT- qPCRs targeting the neuraminidase gene (isolates sorted by NA subtype/lineage)
Isolate identification
Lineage RT- qPCR (Ct- values)
HA NA M1.2 N1all N1pdm N2
A/Swine/Germany/R96/2011 H3 N2 15.0 neg. neg. 15.2
A/Swine/Germany/R76/2011 H3 N2 18.1 neg. neg. 19.3
A/Waterfowl/Germany/2311/2009 H3 N8 neg. neg. neg. neg.
A/Germany- BW/23/2007 B B neg. neg. neg. neg.
Triplex mixture FAM ROX HEX
neg.: Negative.
TABLE  2  (continued)
TABLE  3 Relative sensitivity of tetraplex HA- and triplex NA- specific RT- qPCRs compared with IAV- generic M- specific amplification
(A)
RNA dilution
H1pdm H1av H1hu H3
M 4plex M 4plex M 4plex M 4plex
0 24.3 22.3 24.5 23.1 22.5 22.9 22.6 21.3
−1 27.2 25.3 26.1 26.6 25.6 26.4 26.1 24.7
−2 30.5 28.9 29.4 30.1 29.1 30.4 29.2 28.4
−3 34.2 33.3 32.8 34.7 32.1 33.8 32.5 33.0
−4 36.6 39.8 35.4 neg. 35.4 neg. 36.1 neg.
−5 neg. neg. neg. neg. neg. neg. neg. neg.
−6 neg. neg. neg. neg. neg. neg. neg. neg.
(B)
RNA dilution
N1aII N1pdm N2
M 3plex M 3plex M 3plex
0 24.5 24.8 24.3 26.0 24.3 25.2
−1 26.1 28.4 27.2 30.0 27.5 28.4
−2 29.4 31.8 30.5 33.6 31.0 32.0
−3 32.8 35.4 34.2 37.2 33.8 34.6
−4 35.4 39.1 36.6 39.7 37.8 38.6
−5 neg. neg. neg. neg. neg. neg.
−6 neg. neg. neg. neg. neg. neg.
neg.: Negative.
Serial 10- fold dilutions of SIV RNA were examined by M- and tetraplex HA- (A) and triplex NA- specific (B) RT- qPCRs.
H1pdm, N1pdm—A/Germany- MV/R26/2011; H1av N1av—A/Swine/Germany/AR1738/2010; H1huN2—A/Swine/Germany/AR1141/2014; H3N2—A/
Swine/Germany/R655/2012.
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tested negative for IAV RNA were examined. The multiplex RT- qPCRs 
did not yield positive signals for any of the IAV- negative samples (data 
not shown). Subtyping results obtained by the newly developed mul-
tiplex RT- qPCRs for M- positive isolates and samples were compared 
to those generated by conventional RT- PCR and amplicon Sanger 
sequencing. For this purpose, pan- HA and pan- NA RT- PCRs were 
used as published by Gall et al.32,33 (2008, 2009).
Tables 5A/B compares subtyping results by HA and NA amplicon 
sequencing and by HA and NA multiplex RT- qPCRs for clinical SIV iso-
lates. Test of all RNAs extracted from isolates indicated high virus loads 
as indicated by the M- specific Cq values (range 16–23). All the HA and 
NA subtypes were unambiguously assignable by multiplex RT- qPCRs with 
the exception of three isolates for which no signal was obtained in the HA 
tetraplex RT- qPCR (Table 5A). Full- length sequences of genome segment 
4 encoding the HA protein were generated from these three isolates and 
the sequences compared to the oligonucleotide sequence of the primers 
and probe used in the subtyping RT- qPCRs. This analysis revealed a con-
siderable number of mismatches (Fig. S1a). Also, the products of the tetra-
plex RT- qPCR of these isolates were examined by gel electrophoresis (Fig. 
S1b), but no specific amplicons were detected. In two cases (AR1123/15 
and 2196/15, Table 5A), the multiplex RT- qPCRs detected the presence 
of a mixture of H1av and H1hu subtypes in the same isolate.
Haemagglutinin and NA subtypes could be assigned to all of the 
clinical samples when tested by the multiplex RT- qPCRs (Table 5C/D); 
however, this sample type revealed a greater variation in viral loads 
(range 21–35) compared with the cell- grown isolates.
Amplicon sequencing based on the pan- HA/pan- NA RT- PCRs 
described by Gall et al.32,332008/2009 was used to verify subtyping 
results generated by multiplex RT- qPCRs. However, 9 of 27 isolates 
and 23 of 27 clinical samples failed to yield reliable HA sequenc-
es (Table 5, “questionable”) or failed to produce any amplicons at all 
(Table 5, “failed”). The NA subtyping was affected at a much lower rate 
(one isolate and six clinical samples failed). These results prompted us 
to establish updated primers of the pan- HA PCR that provided a better 
match with European SIV and yielded enhanced amplification sensitiv-
ity. Modified primers are listed in Table 1B. Using the updated pan- HA 
primer set in a multiplex RT- PCR (termed “pan- HA- SIV”), it was pos-
sible to sequence amplicons for all 9 isolates which had failed before, 
and for 16 of the 23 failed clinical samples (Table 5).
Finally, a harmonized diagnosis was made by combining the results 
of the multiplex RT- qPCR and the RT- PCR/amplicon sequencing: in all 
cases for which results for both methods were available, fully matching 
subtyping results were obtained for both HA and NA (Table 5A–D). For 
seven HA samples for which also the updated primer set failed to pro-
duce an amplicon and for one failed NA sample, multiplex RT- qPCRs 
were able to assign a subtype.
4  | DISCUSSION
Despite the fact that zoonotic and even pandemic potential in SIV 
has been noticed repeatedly, no sustained government- administrated 
TABLE  4 Detection of mixtures of different European SIV HA 
and NA lineages by tetraplex HA- (A) and triplex NA- specific (B) 
RT- qPCRs
(A)
Virus
RNA 
percentage
4plex RT- qPCR (Ct- values)
H1pdm H1av H1hu H3
H1pdm/H1av 95/5 26.1 35.8 neg. neg.
H1pdm/H1av 50/50 27.1 28.8 neg. neg.
H1pdm/H1av 5/95 31.0 27.6 neg. neg.
H1pdm/H3 95/5 25.9 neg. neg. 32.3
H1pdm/H3 50/50 27.0 neg. neg. 25.2
H1pdm/H3 5/95 31.2 neg. neg. 24.1
H1pdm/H1hu 95/5 26.0 neg. 30.4 neg.
H1pdm/H1hu 50/50 27.0 neg. 25.4 neg.
H1pdm/H1hu 5/95 31.5 neg. 24.6 neg.
H1hu/H3 95/5 neg. neg. 24.7 30.8
H1hu/H3 50/50 neg. neg. 25.5 25.6
H1hu/H3 5/95 neg. neg 30.6 24.3
H1hu/H1av 95/5 neg. 27.7 27.7 neg.
H1hu/H1av 50/50 neg. 28.7 25.6 neg.
H1hu/H1av 5/95 neg. 33.3 24.4 neg.
H1av/H3 95/5 neg. 26.9 neg. 30.5
H1av/H3 50/50 neg. 28.2 neg. 25.5
H1av/H3 5/95 neg. 33.3 neg. 24.1
(B)
Virus
RNA 
percentage
3plex RT- qPCRs (Ct- values)
N1all N1pdm N2
N1pdm/N1av 95/5 26.3 26.6 neg.
N1pdm/N1av 50/50 26.4 27.7 neg.
N1pdm/N1av 5/95 26.5 31.3 neg.
N1pdm/N2 (H3) 95/5 26.5 26.2 29.3
N1pdm/N2 (H3) 50/50 27.5 27.6 26.7
N1pdm/N2 (H3) 5/95 30.6 31.6 26.2
N1av/N2 (H3) 95/5 26.0 neg. 29.5
N1av/N2 (H3) 50/50 27.0 neg. 26.9
N1av/N2 (H3) 5/95 29.8 neg. 25.8
neg.: Negative.
For tetraplex HA RT- qPCR mixtures, RNA extracted from the following SIV iso-
lates was mixed: H1N1pdm—A/Swine/Germany/1760/2014; H1N1av—A/
Swine/Germany/AR1738/2010; H1huN2—A/Swine/Germany/AR1146/2014; 
H3N2—A/Swine/Germany/R655/2012.
Triplex NA RT- qPCR mixtures consisted of RNA extracted from the 
 following SIV isolates: H1N1pdm—A/Swine/Germany/1759/2014; H1N1av— 
A/Swine/Germany/AR1696/2014; H3N2—A/Swine/Germany/R655/ 
2012.
The relative amount of RNA was normalized to a dilution that generated a 
Cq value of 25- 26 using the M- specific RT- qPCR for all isolates. Then, the 
mixtures were prepared to yield the percentage values indicated in the 
second column of the tables.
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TABLE  5 Haemagglutinin and neuraminidase subtyping of RNA of European SIV extracted from isolates (A, B) or from clinical samples (C, D) 
by multiplex RT- qPCR (this study) or conventional multiplex RT- PCR and Sanger sequencing
(A) SIV isolates, HA
Isolate identification RT- qPCR (Ct- values) RT- PCR/sequencing
Harmonized 
diagnosis
Sample Country Subtype M1.2 H1pdm H1av H1hu H3
HA 
Full- length panHA
panHA- 
SIV HA
AR 1279/15 ES H1avN1av 16.8 neg. 34.4 neg. neg. H1av H1av
AR 1340/15 FR H1avN1av 22.8 neg. 23.1 neg. neg. H1av H1av
AR 1348/15 FR H1avN1av 16.0 neg. 19.1 neg. neg. H1av H1av
AR 2618/15 BE H1avN1av 16.1 neg. 23.6 neg. neg. Questionable H1av H1av
AR 2754/15 FR H1avN1av 18.6 neg. 18.4 neg. neg. Failed H1av H1av
AR 2778/15 FR H1avN1av 17.3 neg. 19.1 neg. neg. Failed H1av H1av
AR 2783/15 FR H1avN1av 18.6 neg. 20.1 neg. neg.  H1av H1av
AR 2667/15 DK H1avN2 27.7 neg. 19.0 neg. neg. Questionable H1av H1av
AR 2759/15 UK H1avN2 23.3 neg. neg. neg. neg. Failed H1av H1av
AR 3067/15 DK H1avN2 14.7 neg. 17.2 neg. neg.  Questionable H1av H1av
AR 1123/15 FR H1av/hu 20.6 neg. 22.3 22.3 neg. H1av/hu H1av/hu
AR 2196/15 FR H1av/hu 18.2 neg. 20.0 26.3 neg.  Failed H1av H1av/hu
AR 1359/15 FR H1huN2 18.0 neg. neg. neg. neg. H1hu H1hu
AR 1372/15 ES H1huN2 16.2 neg. neg. 22.1 neg. H1hu H1hu
AR 2023/15 FR H1huN2 19.0 neg. neg. 30.6 neg. H1hu H1hu
AR 2829/15 DE H1huN2 16.3 neg. neg. 26.2 neg. H1hu H1hu
AR 647/15 NL H1huN1av 18.7 neg. neg. 20.5 neg. H1hu H1hu
AR 2056/15 NL H1huN1av 19.1 neg. neg. 20.2 neg. H1hu H1hu
AR 2082/15 NL H1huN1av 19.7 neg. neg. 20.5 neg. H1hu H1hu
AR 1855/15 DK H1pdmN1pdm 17.9 18.9 neg. neg. neg. H1pdm H1pdm
AR 2675/15 FR H1pdmN1pdm 18.3 21.1 neg. neg. neg. Questionable H1pdm H1pdm
AR 2749/15 DE H1pdmN2 17.4 19.9 neg. neg. neg. H1pdm H1pdm
AR 531/15 NL H3N2 19.6 neg. neg. neg. 18.1 Questionable H3 H3
AR 543/15 NL H3N2 20.2 neg. neg. neg. 17.6 H3 H3
AR 1203/15 BE H3N2 22.6 neg. neg. neg. 20.2 H3 H3
AR 1204/15 BE H3N2 19.1 neg. neg. neg. 18.1 H3 H3
AR 3179/15 NL H3N2 13.2 neg. neg. neg. neg. H3 H3
(B) SIV isolates, NA
Isolate identification RT- qPCR (Ct- values) RT- PCR/sequencing
Harmonized 
diagnosis
Sample Country Subtype M1.2 N1all N1pdm N2 NA Full- length panNA NA
AR 1279/15 ES H1avN1av 16.8 26.1 neg. neg. N1 N1av
AR 1340/15 FR H1avN1av 22.8 22.8 neg. neg. N1 N1av
AR 1348/15 FR H1avN1av 16.0 17.9 neg. neg. N1 N1av
AR 2618/15 BE H1avN1av 16.1 16.4 neg. neg. N1 N1av
AR 2754/15 FR H1avN1av 18.6 17.4 neg. neg. N1 N1av
AR 2778/15 FR H1avN1av 17.3 19.7 neg. neg. N1 N1av
AR 2783/15 FR H1avN1av 18.6 21.2 neg. neg. N1 N1av
AR 2667/15 DK H1avN2 27.7 neg. neg. 19.4 N2 N2
AR 2759/15 UK H1avN2 23.3 neg. neg. 25.3 N2 N2
(Continues)
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(B) SIV isolates, NA
Isolate identification RT- qPCR (Ct- values) RT- PCR/sequencing
Harmonized 
diagnosis
Sample Country Subtype M1.2 N1all N1pdm N2 NA Full- length panNA NA
AR 3067/15 DK H1avN2 14.7 neg. neg. 19.4 N2 N2
AR 1123/15 FR H1av/hu 20.6 20.1 neg. neg. N1 N1av
AR 2196/15 FR H1av/hu 18.2 17.7 neg. neg. N1 N1av
AR 1359/15 FR H1huN2 18.0 neg. neg. 18.4 Failed N2
AR 1372/15 ES H1huN2 16.2 neg. neg. 17.6 N2 N2
AR 2023/15 FR H1huN2 19.0 neg. neg. 31.1 N2 N2
AR 2829/15 DE H1huN2 16.3 neg. neg. 17.6 N2  N2
AR 647/15 NL H1huN1av 18.7 17.9 neg. neg. N1 N1av
AR 2056/15 NL H1huN1av 19.1 18.7 neg. neg. N1 N1av
AR 2082/15 NL H1huN1av 19.7 18.5 neg. neg. N1 N1av
AR 1855/15 DK H1pdmN1pdm 17.9 20.5 18.4 neg. N1pdm N1pdm
AR 2675/15 FR H1pdmN1pdm 18.3 19.9 19.1 neg. N1pdm N1pdm
AR 2749/15 DE H1pdmN2 17.4 neg. neg. 21.1 N2  N2
AR 531/15 NL H3N2 19.6 neg. neg. 25.3 N2 N2
AR 543/15 NL H3N2 20.2 neg. neg. 32.2 N2 N2
AR 1203/15 BE H3N2 22.6 neg. neg. 28.9 N2 N2
AR 1204/15 BE H3N2 19.8 neg. neg. 25.4 N2 N2
AR 3179/15 NL H3N2 13.2 neg. neg. 13.9 N2 N2
(C) Clinical samples, HA
Sample identification RT- qPCR (Ct- values) RT- PCR/sequencing
Harmonized 
diagnosis
Sample Country Subtype M1.2 H1pdm H1av H1hu H3 panHA panHA- SIV HA
AR 849/15 FR H1avN1av 22.0 neg. 27.2 neg. neg. Failed H1av H1av
AR 1350/15 FR H1avN1av 29.9 neg. 32.5 neg. neg. Failed H1av H1av
AR 1520/15 FR H1avN1av 25.8 neg. 22.5 neg. neg. H1av H1av
AR 1766/15 DE H1avN1av 20.1 neg. 21.0 neg. neg. H1av H1av
AR 2089/15 NL H1avN1av 35.0 neg. 25.8 neg. neg. Failed Failed H1av
AR 2297/15 FR H1avN1av 29.2 neg. 32.9 neg. neg. Failed Failed H1av
AR 2435/15 ES H1avN1av 32.3 neg. 32.2 neg. neg. Failed Failed H1av
AR 3298/15 FR H1avN1av 27.7 neg. 28.2 neg. neg. Failed H1av H1av
AR 682/15 ES H1avN2 26.5 neg. 29.5 neg. neg. Failed H1av H1av
AR 856/15 ES H1avN2 28.5 neg. 31.5 neg. neg. Failed H1av H1av
AR 1051/15 ES H1avN2 30.6 neg. 38.3 neg. neg. Failed Failed H1av
AR 1992/15 DK H1avN2 34.8 neg. 35.0 neg. neg. Failed Failed H1av
AR 1996/15 DK H1avN2 26.8 neg. 24.3 neg. neg. Failed H1av H1av
AR 2662/15 DK H1avN2 34.5 neg. 25.9 neg. neg. Failed H1av H1av
AR 2975/15 DK H1avN2 24.6 neg. 28.5 neg. neg. Failed Failed H1av
AR 482/15 NL H1huN2 24.4 neg. neg. 28.9 neg. Failed H1hu H1hu
AR 1355/15 FR H1huN2 26.8 neg. neg. 30.3 neg. Failed H1hu H1hu
AR 3002/15 BE H1huN2 22.9 neg. neg. 26.2 neg. Failed H1hu H1hu
AR 3437/15 NL H1huN2 25.9 neg. neg. 27.9 neg. Failed H1hu H1hu
AR 2061/15 NL H1huN1av 26.5 neg. neg. 21.2 neg. H1hu  H1hu
TABLE  5  (continued)
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(C) Clinical samples, HA
Sample identification RT- qPCR (Ct- values) RT- PCR/sequencing
Harmonized 
diagnosis
Sample Country Subtype M1.2 H1pdm H1av H1hu H3 panHA panHA- SIV HA
AR 1843/15 DK H1pdmN1pdm 25.3 25.2 neg. neg. neg. Failed H1pdm H1pdm
AR 2652/15 DK H1pdmN1pdm 24.9 24.7 neg. neg. neg Failed H1pdm H1pdm
AR 3404/15 FR H1pdmN1pdm 29.0 27.4 neg. neg. neg. Failed H1pdm H1pdm
AR 112/16 FR H1pdmN1pdm 25.3 24.1 neg. neg. neg. Failed H1pdm H1pdm
AR 2906/15 UK H1pdmN1av 34.7 35.6 neg. neg neg. Failed Failed H1pdm
AR 544/15 NL H3N2 26.0 neg. neg. neg. 34.2 Failed H3 H3
AR 220/16 NL H3N2 22.3 neg neg. neg. 24.3 H3  H3
(D) Clinical samples, NA
Sample identification RT- qPCR (Ct- values)
RT- PCR/
sequencing
Harmonized 
diagnosis
Sample Country Subtype M1.2 N1all N1pdm N2 panNA NA
AR 849/15 FR H1avN1av 22.0 22.1 neg. neg. N1 N1av
AR 1350/15 FR H1avN1av 29.9 29.4 neg. neg. N1 N1av
AR 1520/15 FR H1avN1av 25.8 24.6 neg. neg. N1 N1av
AR 1766/15 DE H1avN1av 20.1 19.3 neg. neg. N1 N1av
AR 2089/15 NL H1avN1av 35.0 32.6 neg. neg. Failed N1av
AR 2297/15 FR H1avN1av 29.2 29.0 neg. neg. N1 N1av
AR 2435/15 ES H1avN1av 32.3 30.6 neg. neg. Failed N1av
AR 3298/15 FR H1avN1av 27.7 26.9 neg. neg. N1 N1av
AR 682/15 ES H1avN2 26.5 neg. neg. 30.6 N2 N2
AR 856/15 ES H1avN2 28.5 neg. neg. 31.7 N2 N2
AR 1051/15 ES H1avN2 30.6 neg. neg. 32.1 Failed N2
AR 1992/15 DK H1avN2 34.8 neg. neg. 35.6 Failed N2
AR 1996/15 DK H1avN2 26.8 neg. neg. 25.4 Failed N2
AR 2662/15 DK H1avN2 34.5 neg. neg. 27.9 N2 N2
AR 2975/15 DK H1avN2 24.6 neg. neg. 26.0 N2 N2
AR 482/15 NL H1huN2 24.4 neg. neg. 27.4 N2 N2
AR 1355/15 FR H1huN2 26.8 neg. neg. 28.1 N2 N2
AR 3002/15 BE H1huN2 22.9 neg. neg. 23.2 N2 N2
AR 3437/15 NL H1huN2 25.9 neg. neg. 25.9 N2 N2
AR 2061/15 NL H1huN1av 26.5 23.6 neg. neg. N1 N1av
AR 1843/15 DK H1pdmN1pdm 25.3 26.2 25.4 neg. N1pdm N1pdm
AR 2652/15 DK H1pdmN1pdm 24.9 23.3 22.2 neg. N1pdm N1pdm
AR 3404/15 FR H1pdmN1pdm 29.0 28.5 26.8 neg. N1pdm N1pdm
AR 112/16 FR H1pdmN1pdm 25.3 26.1 23.4 neg. N1pdm N1pdm
AR 2906/15 UK H1pdmN1av 34.7 34.8 neg. neg. Failed N1av
AR 544/15 NL H3N2 26.0 neg. neg. 31.5 N2 N2
AR 220/16 NL H3N2 22.3 neg. neg. 21.9 N2 N2
neg.: Negative.
“Sample number” indicates the identity of a sample (AR NNNN) and the year of sampling (/YR).
Bold- face subtype signal HA/NA reassortants.
“failed” and “questionable” indicate that a no or only very short nucleotide sequences were generated.
“Harmonized results” identifies the subtype pattern as defined by combined results from RT- qPCRs and RT- PCR/sequencing.
TABLE  5  (continued)
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surveillance programmes currently operate in Europe, with the sole 
exception of France, that target SIV in swine populations.18 Technical 
problems and high costs associated with previously established SIV 
detection and subtyping tools may at least in part be related to the 
diffidence of embarking on monitoring on a larger scale. This discrep-
ancy was taken as an incentive to develop more productive SIV sub-
typing tools.
Real- time PCR is an established method in most routine diagnos-
tic laboratories. The use of multiplex assays allows time- efficient and 
cost- effective examination of several parameters in the same tube.40 
The ultimate goal of this study was to distinguish HA and NA lineages 
of SIV circulating in Europe and was achieved by the establishment of 
two multiplex RT- qPCRs. Selection of primers and probes proved to 
be difficult as sequence stretches that are broadly conserved within 
one lineage (inclusivity) but distinct to all other ones (exclusivity) are 
scarce, especially in the HA genome segment. Therefore, primers and 
probes had to be constructed with a number of degenerate positions. 
In addition, mixtures of up to four primers for the same target had 
to be used. Finally, for the distinction of the human- derived HA H1 
lineage of SIV (H1hu), a double- priming strategy had to be implement-
ed. Validation of the analytical specificity of primers and probes in the 
uni- and multiplex formats confirmed their lineage- specific reactivity, 
and therefore, detection of double infections with different lineages in 
the same sample was possible with high reliability. Significant advan-
tages of the multiplex RT- qPCRs over the original amplicon sequenc-
ing system were evident, especially for direct subtyping from clinical 
samples. Even samples with marginal RNA contents (Cq values up to 
35) could be subtyped by RT- qPCRs but failed to react even in the 
updated amplicon sequencing system, pan- HA- SIV.
When analysing RNA from SIV isolates, limits of the inclusivity of 
the multiplex RT- qPCR became evident: despite the presence of high 
RNA loads in the samples (as evidenced by M RT- qPCR), one isolate 
each of the H1av, H1hu and H3 lineage was not detected by the tetra-
plex HA- specific RT- qPCR; however, amplicon sequencing succeeded 
in all three cases to identify the HA subtype. Full- length sequencing 
of the HA open reading frame of these isolates revealed a substantial 
number of mutated positions affecting the binding of both primers and 
probes (Table 6) which likely prevented amplification (Figs S1 and S2). 
A constant control and timely adaptation of oligonucleotides in the 
multiplex RT- qPCRs is essential.
While the isolates and clinical samples used here for validation 
purposes only represent a small fraction of the ongoing monitoring 
project, the comparatively large fraction of HA/NA reassortants is 
TABLE  6 Mismatches of primers and probes for the three SIV 
isolates which remained negative in the tetraplex HA RT- qPCR 
(Table 5A)
Isolate identification
Primer MismatchesSample Country Subtype
AR 
2759/15
UK H1avN2 H1av_Sw_Fn 2
H1av_Sw_R1 8
H1av_Sw_R2 7
H1av_Sw_HEX_1 4
AR 
1359/15
FR H1huN2 H1hu_Sw_F_2 1
H1[N2]_Swine_Fw 2
H1hu_Sw_R_2 3
H1[N2]_Swine_Rv 1
H1hu_Sw_ROX 2
AR 
3179/15
NL H3N2 H3_Sw_F2 2
H3_Sw_R2 2
H3_Sw_Q670 2
Full- length HA sequences were established of the genome segment 4 of 
these viruses to align oligonucleotide sequences of primers and probes. 
Sequences are available from the Epiflu database at GISAID: EPI734316, 
EPI734466 and EPI734318.
F IGURE  1 Proposed diagnostic 
algorithm for detection and subtyping of 
swine influenza viruses in Europe based 
on one- step multiplex RT- qPCRs. Step 1 
depicts an IAV- generic one- step RT- qPCR, 
for example targeting the M gene segment; 
an internal control (IC2) is essentially 
included in this duplex RT- qPCR. For 
IAV RNA- positive samples, subtyping is 
attempted in step 2 employing the one- step 
tetraplex HA- and the triplex NA- specific 
RT- qPCRs developed in this study. Only 
for cases in which HA or NA subtype/
lineage cannot be assigned by these RT- 
qPCRs, step 3 is required and HA and/or 
NA amplicons need to be generated by 
conventional one- step RT- PCR for Sanger 
amplicon sequencing and BLAST searches 
to finalize subtyping
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notable (Table 5, bold- face samples). Increasing diversity of genotypes 
and HA/NA reassortant patterns, especially within subtype H1, has 
previously been noticed.18,21,31,41 No reassortants were detected here 
for the H3 subtype.
Based on the results of this study, we propose an algorithm, depict-
ed in Figure 1, for the detection and subtyping of porcine influenza 
viruses currently circulating in Europe. Any sample that tested positive 
in a generic influenza A virus RT- qPCR (e.g. the modified Spackman M 
PCR enhanced with an internal control) is subjected in a second step 
to tetraplex HA- and triplex NA- specific RT- qPCRs which enable the 
delineation of four HA and three NA lineages/subtypes, respectively, 
of European SIV. In case either of these multiplex PCRs yields nega-
tive results, the subtype has to be determined by amplicon sequenc-
ing. The updated conventional pan- HA- SIV and the original pan- NA 
RT- PCRs previously developed by Gall et al.33 (2009) can be used as 
a complementing amplicon sequencing system. Alternatively, other 
published RT- PCR protocols for the generation of lineage- specific SIV 
HA and NA amplicons might be used.28
The newly developed multiplex RT- qPCRs provide basic tools for 
a sustained monitoring programme of swine influenza in Europe. In 
addition, virus isolation on selected samples is required to allow fur-
ther antigenic, in- depth genetic and biological characterizations of cir-
culating virus strains.
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